Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response

Nature Immunology

Volumn 7, Issue 10, 2006, Pages 1066-1073

  Montminy, Sara W ^a   Khan, Naseema ^a   McGrath, Sara ^b   Walkowicz, Mitchell J ^a   Sharp, Fiona ^a   Conlon, Joseph E ^a   Fukase, Koichi ^c   Kusumoto, Shoichi ^c   Sweet, Charles ^a   Miyake, Kensuke ^d   Akira, Shizuo ^e   Cotter, Robert J ^b   Goguen, Jon D ^a   Lien, Egil ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; LIPID A; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN MD 2; TOLL LIKE RECEPTOR 4; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BODY TEMPERATURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CONVALESCENCE; ENZYME ACTIVATION; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; LIPOGENESIS; MAMMAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC DISEASE; WILD TYPE; YERSINIA PESTIS;

ACYLTRANSFERASES; ANIMALS; ANTIGENS, CD14; CELLS, CULTURED; ESCHERICHIA COLI PROTEINS; HUMANS; LIPID A; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED STRAINS; PLAGUE; PLAGUE VACCINE; TOLL-LIKE RECEPTOR 4; VACCINATION; VIRULENCE; VIRULENCE FACTORS; YERSINIA PESTIS;

EID: 33748875900     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1386     Document Type: Article

References (50)

1. Perry, R.D. & Fetherston, J.D. Yersinia pestis-etiologic agent of plague. Clin. Microbiol. Rev. 10, 35-66 (1997).
2. Sodeinde, O.A. et al. A surface protease and the invasive character of plague. Science 258, 1004-1007 (1992).
3. Nakajima, R., Motin, V.L. & Brubaker, R.R. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect. Immun. 63, 3021-3029 (1995).
4. Cornelis, G.R. The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell Biol. 3, 742-752 (2002).
5. Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511 (2004).
6. Liew, F.Y., Xu, D., Brint, E.K. & O'Neill, L.A. Negative regulation of Toll-like receptormediated immune responses. Nat. Rev. Immunol. 5, 446-458 (2005).
7. Hoshino, K. et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749-3752 (1999).
8. Lien, E. et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105, 497-504 (2000).
9. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282, 2085-2088 (1998).
10. Raetz, C.R.H. & Whitfield, C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635-700 (2002).
11. Shimazu, R. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782 (1999).
12. Miyake, K. Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol. 12, 186-192 (2004).
13. Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J. & Mathison, J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433 (1990).
14. Zähringer, U., Lindner, B. & Rietschel, E.T. in Endotoxin in Health and Disease (eds. Brade, H., Opal, S.M., Vogel, S.N. & Morrison, D.C.) 93-114 (Marcel Dekker, New York, 1999).
15. Dixon, D.R. & Darveau, R.P. Lipopolysaccharide heterogeneity: Innate host responses to bacterial modification of lipid a structure. J. Dent. Res. 84, 584-595 (2005).
16. Kawahara, K., Tsukano, H., Watanabe, H., Lindner, B. & Matsuura, M. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect. Immun. 70, 4092-4098 (2002).
17. Rebeil, R., Ernst, R.K., Gowen, B.B., Miller, S.I. & Hinnebusch, B.J. Variation in lipid A structure in the pathogenic yersiniae. Mol. Microbiol. 52, 1363-1373 (2004).
18. Knirel, Y.A. et al. Temperature-dependent variations and intraspecies diversity of the structure of the lipopolysaccharide of Yersinia pestis. Biochemistry 44, 1731-1743 (2005).
19. Loppnow, H. et al. IL-1 induction capacity of defined lipopolysaccharide partial structures. J. Immunol. 142, 3229-3238 (1989).
20. Golenbock, D.T., Hampton, R.Y., Qureshi, N., Takayama, K. & Raetz, C.R.H. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J. Biol. Chem. 266, 19490-19498 (1991).
21. Carty, S.M., Sreekumar, K.R. & Raetz, C.R.H. Effect of cold shock on lipid A biosynthesis in Escherichia coli. Induction at 12 degrees C of an acyltransferase specific for palmitoleoyl-acyl carrier protein. J. Biol. Chem. 274, 9677-9685 (1999).
22. Vorachek-Warren, M.K., Carty, S.M., Lin, S., Cotter, R.J. & Raetz, C.R.H. An Escherichia coli mutant lacking the cold shock-induced palmitoleoyltransferase of lipid A biosynthesis: Absence of unsaturated acyl chains and antibiotic hypersensitivity at 12 degrees C. J. Biol. Chem. 277, 14186-14193 (2002).
23. Deng, W. et al. Genome sequence of Yersinia pestis KIM. J. Bacteriol. 184, 4601-4611 (2002).
24. 2+-response plasmid pCD1 of Yersinia pestis KIM5. Infect. Immun. 66, 4611-4623 (1998).
25. Parkhill, J. et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413, 523-527 (2001).
26. Akashi, S. et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int. Immunol. 13, 1595-1599 (2001).
27. Hajjar, A.M., Ernst, R.K., Tsai, J.H., Wilson, C.B. & Miller, S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3, 354-359 (2002).
28. Poltorak, A., Ricciardi-Castagnoli, P., Citterio, S. & Beutler, B. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc. Natl. Acad. Sci. USA 97, 2163-2167 (2000).
29. Schromm, A.B. et al. Molecular genetic analysis of an endotoxin nonresponder mutant Cell Line. A point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J. Exp. Med. 194, 79-88 (2001).
30. Nagai, Y. et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3, 667-672 (2002).
31. Skurnik, M. & Bengoechea, J.A. The biosynthesis and biological role of lipopolysaccharide O-antigens of pathogenic Yersiniae. Carbohydr. Res. 338, 2521-2529 (2003).
32. Vinogradov, E.V. et al. The core structure of the lipopolysaccharide from the causative agent of plague, Yersinia pestis. Carbohydr. Res. 337, 775-777 (2002).
33. Jiang, Z. et al. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6, 565-570 (2005).
34. Huber, M. et al. R-form LPS, the master key to the activation of TLR4/ MD-2-positive cells. Eur. J. Immunol. 36, 701-711 (2006).
35. van Duin, D., Medzhitov, R. & Shaw, A.C. Triggering TLR signaling in vaccination. Trends Immunol. 27, 49-55 (2006).
36. Parent, M.A. et al. Cell-mediated protection against pulmonary Yersinia pestis infection. Infect. Immun. 73, 7304-7310 (2005).
37. Ulevitch, R.J. Therapeutics targeting the innate immune system. Nat. Rev. Immunol. 4, 512-520 (2004).
38. Agrawal, S. & Kandimalla, E.R. Modulation of Toll-like receptor 9 responses through synthetic immunostimulatory motifs of DNA. Ann. NY Acad. Sci. 1002, 30-42 (2003).
39. Goguen, J.D., Yother, J. & Straley, S.C. Genetic analysis of the low calcium response in Yersinia pestis mu d1(Ap lac) insertion mutants. J. Bacteriol. 160, 842-848 (1984).
40. Westphal, O., Luderitz, O. & Bister, F. Uber die extraktion von bacterien mit phenol/wasser. Z. Naturforsch. B 7, 148-155 (1952).
41. Hirschfeld, M., Ma, Y., Weis, J.H., Vogel, S.N. & Weis, J.J. Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165, 618-622 (2000).
42. Liu, W.-C., Oikawa, M., Fukase, K., Suda, Y. & Kusumoto, S. A divergent synthesis of lipid A and its chemically stable unnatural analogues. Bull. Chem. Soc. Jpn. 72, 1377-1385 (1999).
43. Latz, E. et al. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277, 47834-47843 (2002).
44. Bandyopadhyay, S.K., Leonard, G.T., Jr, Bandyopadhyay, T., Stark, G.R. & Sen, G.C. Transcriptional induction by double-stranded RNA is mediated by interferon-stimulated response elements without activation of interferon-stimulated gene factor 3. J. Biol. Chem. 270, 19624-19629 (1995).
45. Yamamoto, M. et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4, 1144-1150 (2003).
46. Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643 (2003).
47. Yamamoto, M. et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420, 324-329 (2002).
48. Takeuchi, O. et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11, 443-451 (1999).
49. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143-150 (1998).
50. Moore, K.J. et al. Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J. Immunol. 165, 4272-4280 (2000).